Used as a key chiral intermediate in the synthesis of pharmaceuticals, particularly in the development of protease inhibitors and antiviral agents. Its structure supports the formation of stereoselective bonds, making it valuable in asymmetric synthesis. Commonly employed in the preparation of active pharmaceutical ingredients (APIs) where the (R)-enantiomer provides optimal biological activity. Also utilized in medicinal chemistry research for constructing nitrogen-containing heterocycles with improved metabolic stability and binding affinity.